Marco Meglio - Journalist Profile | Connect with top journalists

Beats

Biography

Content

Total articles 3695

• Available on paid plans

  FDA Approves CT-132 as First Digital Therapeutic for Preventive Treatment of Episodic Migraine

  By Marco Meglio Verified

  Apr. 15, 2025

• Available on paid plans

  Highlighting Early-Stage Promising Data of AAK1 Inhibitor SAT-3247 in Duchenne Muscular Dystrophy: Phil Lambert, PhD

  By Phil Lambert, Marco Meglio Verified

  Apr. 15, 2025

• Available on paid plans

  Highlighting Early-Stage Promising Data of AAK1 Inhibitor SAT-3247 in Duchenne Muscular Dystrophy: Phil Lambert, PhD

  By Phil Lambert, Marco Meglio Verified

  Apr. 15, 2025

As seen in

Company Info

NeurologyLive

NeurologyLive is a multimedia platform focused on delivering the latest news and insights in the field of neurology. It serves as a valuable resource for healthcare professionals, particularly those treating neurological diseases. The platform offers a combination of print and digital media, ensuring that busy clinicians stay informed about significant developments in neurology. The services provided by NeurologyLive include breaking news on drug approvals, clinical trials, and emerging trends in neurological care. It features expert interviews with leading neurologists, offering insights into the latest research and clinical practices. The use of multimedia content makes the information accessible and engaging for its audience. NeurologyLive targets healthcare professionals such as neurologists, clinicians, and researchers. It has established strategic partnerships with organizations like the Consortium of Multiple Sclerosis Centers, enhancing its credibility and reach within the neurology community. Its comprehensive coverage and expert engagement position NeurologyLive as a trusted source for the latest developments in the field.